Abstract
OP-20 Radiological response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI®) for resectable liver metastases from colorectal cancer does not correlate with pathological response or long-term outcome
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
